Monica Faronato
82 Wood Lane
London, ENG W120BZ, United Kingdom
London, ENG W120BZ, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
MYC deregulation sensitizes cancer cells to N-myristoyltransferase inhibition.
Journal: Cell reports
Published: June 25, 2025
Inhibition of vaccinia virus L1 N-myristoylation by the host N-myristoyltransferase inhibitor IMP-1088 generates non-infectious virions defective in cell entry.
Journal: PLoS pathogens
Published: June 10, 2022
Author Correction: SREBP1 drives keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer.
Journal: Nature communications
Published: August 21, 2019
Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion.
Journal: Nature communications
Published: August 08, 2019
Validation and Invalidation of Chemical Probes for the Human N-myristoyltransferases.
Journal: Cell chemical biology
Published: January 09, 2019
Dynamic Protein Acylation: New Substrates, Mechanisms, and Drug Targets.
Journal: Trends in biochemical sciences
Published: January 12, 2017
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion.
Journal: Nature communications
Published: February 20, 2015
The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancer.
Journal: Oncotarget
Published: February 18, 2015
Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cells.
Journal: Breast cancer research and treatment
Published: August 26, 2014
Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells.
Journal: Breast cancer research : BCR
Published: September 11, 2013
Last Updated: 09/26/2026